Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Banerjee

Showing results (441-450 of 584) with videos related to

Pageof 59
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Frontiers in Immunology|March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK CellsEnli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Nature Communications|November 20, 2014
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunityKatharina L Willmann, Stefanie Klaver, Figen Doğu, et al.
Science Advances|July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineeringLi Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Molecular Cancer Research : MCR|June 6, 2019
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma CellsErika Parasido, George S Avetian, Aisha Naeem, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Immunology|November 1, 2016
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamicsElisabeth Salzer, Deniz Cagdas, Miroslav Hons, et al.
Pageof 59

Showing results (441-450 of 584) with videos related to

Sort By:
Pageof 59
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
PTEN is a negative regulator of NK cell cytolytic functionEdward L Briercheck, Rossana Trotta, Li Chen, et al.
Frontiers in Immunology|March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK CellsEnli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Nature Communications|November 20, 2014
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunityKatharina L Willmann, Stefanie Klaver, Figen Doğu, et al.
Science Advances|July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineeringLi Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T CellsAmanda Olson, Ye Li, David Marin, et al.
Molecular Cancer Research : MCR|June 6, 2019
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma CellsErika Parasido, George S Avetian, Aisha Naeem, et al.
Nature Medicine|January 5, 2024
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Blood Cancer Discovery|October 27, 2025
CD70-Targeting CAR-NK Cells Overcome BCMA Downregulation and Improve Survival in High-Risk Multiple Myeloma ModelsPaul Lin, Sunil Acharya, Francia Reyes-Silva, et al.
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Nature Immunology|November 1, 2016
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamicsElisabeth Salzer, Deniz Cagdas, Miroslav Hons, et al.
Pageof 59